Differential activation of dopaminergic systems in rat brain basal ganglia by morphine and methamphetamine

Neuroscience
Tomohisa MoriT Suzuki

Abstract

Typical abused drug-induced behavioral changes are ordinarily mediated by the mesolimbic dopaminergic system and even the phenotypes of behavior are different from each other. However, the mechanisms that underlie the behavioral changes induced by these abused drugs have not yet been elucidated. The present study was designed to investigate the mechanisms that underlie how abused drugs induce distinct behavioral changes using neurochemical as well as behavioral techniques in rats. Methamphetamine (2mg/kg) more potently increased dopamine release from the striatum more than that from the nucleus accumbens. In contrast, the administration of morphine (10mg/kg) produced a significant increase in the release of dopamine from the nucleus accumbens, but not the striatum, which is accompanied by a decrease in the release of GABA in the ventral tegmental area. These findings indicate that morphine and methamphetamine differentially regulate dopaminergic systems to produce behavioral changes, even though both drugs have abuse potential through activation of the mesolimbic dopaminergic system.

References

May 1, 1987·Pharmacology, Biochemistry, and Behavior·G D Carr, N M White
Dec 24, 1997·Behavioural Brain Research·D S Segal, R Kuczenski
Jan 4, 1998·Pharmacology, Biochemistry, and Behavior·C J SwansonA E Kelley
Dec 16, 2004·Journal of Pharmacological Sciences·Tomohisa MoriToshiko Sawaguchi
Dec 16, 2004·Journal of Pharmacological Sciences·Tomohisa MoriToshiko Sawaguchi
Jan 13, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Minoru NaritaTsutomu Suzuki
Jun 15, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Christian R Lee, James M Tepper
Oct 22, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Anuradha MadhavanJennifer L Whistler
Jul 6, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Kathleen M GrantRick A Bevins
Sep 21, 2011·Proceedings of the National Academy of Sciences of the United States of America·Marion JalabertFrançois Georges
Jan 19, 2012·The FEBS Journal·Fabio Blandini, Marie-Therese Armentero
Oct 12, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Michel BarrotThomas C Jhou
Nov 13, 2012·Neuron·John D Salamone, Mercè Correa

❮ Previous
Next ❯

Citations

Mar 20, 2016·Behavioural Brain Research·Tomohisa MoriTsutomu Suzuki
Aug 24, 2016·Basic & Clinical Pharmacology & Toxicology·Joseph T Horsfall, Jon E Sprague

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.